In fact, the involvement of DC–T cell interactions in the pathways leading to and perpetuating RA and the effects of inhibiting this process are supported by recent findings on the significant clinical effects of interference with CD80/86–CD28 co-stimulation [50]. Here, CD28 is linked to rheumatoid arthritis.